Previous 10 | Next 10 |
home / stock / nsrgy / nsrgy news
Nestlé S.A. ( OTCPK:NSRGY ): FY Non-GAAP EPS of CHF4.80. Revenue of CHF94.42B (+8.4% Y/Y). Press release For further details see: Nestlé S.A. Non-GAAP EPS of CHF4.80, revenue of CHF94.42B
Summary Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund invests in dividend-paying stocks from around the world. The ETO closed-end fund has underperformed the MSCI World Index, although that is not a perfect benchmark for the fund. The fund appears to be reasonably we...
Summary Tweedy, Browne’s 13F portfolio value decreased from $2.27B to $1.88B this quarter. They increased Ionis Pharmaceuticals while reducing most of the other stakes. Berkshire Hathaway at ~20% of the portfolio is the largest position. This article is part of a se...
Summary Colgate owns some of the best-known oral care, personal care, household cleaning, and pet nutrition brands, has wide global distribution, and is well positioned to capitalize on growing global demand. Its growth and margins over the past five years have been disappointing, in pa...
Over the last five years, share prices of Starbucks (NASDAQ: SBUX) have nearly doubled and significantly outperformed the S&P 500 index. Still, there's good reason to expect another similar run of returns over the next five years. Investors didn't like the company's sluggish s...
Purina Announces Planned Acquisition of Red Collar Pet Foods' Treats Factory in Miami, Oklahoma PR Newswire Addition Will Expand Capabilities for In-House Production of Dog and Cat Treats for Pet Care Leader ST. LOUIS , Feb. 7, 2023 /PRNewswire/ -- N...
Summary Mondelez is a consumer goods business focusing on snacks. The company operates across 160 countries, owning brands such as Oreo. Our view is that economic weakening will not materially impact growth, although it will continue to pressure gross margins due to supply-side issues. ...
Summary Today, we take a look at microbiome therapeutic developer Seres Therapeutics, Inc. Seres Therapeutics appears headed to its first FDA approval and has a strategic partnership with Nestlé S.A. around this endeavor. Will the FDA greenlight trigger a rally in the shares?...
Nestle ( OTCPK:NSRGY ) is likely to hike prices on its products yet again in 2023, per comments made by CEO Mark Schneider to the German press. The executive told the Frankfurter Allgemeine Zeitung that price increases will take effect again this year to “catch upȁ...
Summary In this article, I will give an overview of the portfolio of Unilever PLC and Nestlé S.A. and provide a discussion of their growth and profitability. I will also take a look at their balance sheets, as debt has only known one direction over the past decade - up and to the r...